Stock Message Board http://investorshangout.com/search?q=NVSEF&am...mp;yt1=Go!
Last Updated: 07/20/2014 23:56:25
Current Price and Quotes
Last Price 88.998
Previous Close 88.36 Open 89.08
Daily Range N/A - 89.0803 52wk Range 70.92 - 91.68
Volume 801 Dividend N/A
Average Vol (3m) 23,859 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 58,831,000 57,561,000 59,375,000 51,561,000
Cost of Revenue 19,608,000 18,756,000 18,983,000 14,488,000
Gross Profit 39,223,000 38,805,000 40,392,000 37,073,000
Operating Expenses
Research and Development 9,852,000 9,332,000 9,583,000 9,070,000
Sales, General and Admin. 18,461,000 18,280,000 20,029,000 16,477,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 10,910,000 11,193,000 10,780,000 11,526,000
Income From Continuing Operations
Add'l Income/Expense Items (92,000) (96,000) (2,000) 64,000
Earnings Before Interest and Tax 11,418,000 11,649,000 11,306,000 12,394,000
Interest Expense 683,000 724,000 751,000 692,000
Earnings Before Tax 10,735,000 10,925,000 10,555,000 11,702,000
Income Tax 1,443,000 1,542,000 1,483,000 1,733,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary 600,000 552,000 528,000 804,000
Net Income Cont. Operations 9,892,000 9,935,000 9,600,000 10,773,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 9,292,000 9,383,000 9,072,000 9,969,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 9,292,000 9,383,000 9,072,000 9,969,000
Recent News
Jul 17, 2014 Hopp Acquires LTS Shares From Novartis & BWK
Jul 17, 2014 Santhera Repositions Omigapil in Congenital Muscular Dystrophy and Initiates Clinical Development Program with Public-Private Partners
Jul 17, 2014 Novartis maintained strong innovation momentum in second quarter, while reconfirming full year outlook
Jul 16, 2014 Research and Markets: Global Transdermal Drug Delivery Market 2014-2018 with ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen Pharma & Novartis Dominating
Jul 15, 2014 Banner Alzheimer's Institute Announces Partnership with Novartis in New Study of Alzheimer's Prevention Treatments
Jul 15, 2014 Research and Markets: Global Animal (Companion & Production) Healthcare Market 2014-2019 Featuring Key Companies, Zoetis, Merck, Merial, Bayer and Novartis
Jul 15, 2014 Novartis to license Google "smart lens" technology
Jul 15, 2014 Novartis announces collaboration with Banner Alzheimer's Institute on a pioneering prevention study for Alzheimer's Disease
Jul 11, 2014 Research and Markets: Global Alzheimer's Drugs Market 2014-2018 with Eisai Co. Forest Laboratories, Janssen Pharmaceuticals & Novartis Dominating
Jul 10, 2014 Microbix Sues Novartis for Infringement of its VIRUSMAX® Patent In Europe
1
2
3
4
5
6
7
8
next >
last >>
NVSEF Novartis AG Research DD Guide
Stock Message Board http://investorshangout.com/search?q=NVSEF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/NVSEF/quote
Stock Chart http://www.otcmarkets.com/stock/NVSEF/chart
Company Info http://www.otcmarkets.com/stock/NVSEF/company-info
Recent News http://www.otcmarkets.com/stock/NVSEF/news
Financials http://www.otcmarkets.com/stock/NVSEF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/NVSEF/filings
Short Sales http://www.otcmarkets.com/stock/NVSEF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/NVSEF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/NVSEF/research
Summary http://finance.yahoo.com/q?s=NVSEF
Historical Prices http://finance.yahoo.com/q/hp?s=NVSEF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=NVSEF
Basic Chart http://finance.yahoo.com/q/bc?s=NVSEF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NVSEF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=NVSEF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=NVSEF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=NVSEF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=NVSEF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=NVSEF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=NVSEF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=NVSEF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=NVSEF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=NVSEF
Balance Sheet http://finance.yahoo.com/q/bs?s=NVSEF
Cash Flow http://finance.yahoo.com/q/cf?s=NVSEF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/NVSEF
Market Watch http://www.marketwatch.com/investing/stock/NVSEF
Bloomberg http://www.bloomberg.com/quote/NVSEF:US
Morningstar http://quotes.morningstar.com/stock/s?t=NVSEF
Bussinessweek http://investing.businessweek.com/research/st...cker=NVSEF
Barchart http://www.barchart.com/quotes/stocks/NVSEF
OTC Short Report http://otcshortreport.com/index.php?index=NVSEF
Investopedia http://www.investopedia.com/markets/stocks/NVSEF/?wa=0